Literature DB >> 33532152

The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study.

Ali Bahathig1, Mohammed A Alblowi2, Amna A Alhilali2, Balqees S AlJasim3, Manal Alhelow3, Hamad Aldakheel4, Nasser Alodayani4, Narjes Hikri3.   

Abstract

Introduction Multiple sclerosis (MS) is often associated with depression and anxiety, with no clear prevalence, and the relationship between them is not fully understood. Methods In a cross-sectional study of 365 multiple sclerosis patients selected through a random sampling method from the MS society of Riyadh, Saudi Arabia, we collected data by self-administered questionnaires - the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder (GAD-7) questionnaire - and analyzed by descriptive and analytical statistics. Results Approximately 51.1% of participants had moderate or severe anxiety and 64% of them had depression among community-based multiple sclerosis patients according to Generalized Anxiety Disorder (GAD-7) questionnaire, and according to the PHQ-9 Arabic version about 28.85% showed mild to moderate depression. The MS patients aged 53 to over 60 years showed higher levels of mild anxiety (76.32%) and higher levels of depression ranging from mild to moderate (53.61%) (P = 0.001). While the MS patients younger than 53 years showed moderate to severe anxiety (60.71%) and depression levels (62.32%). In different age group bad health status (37.6%) was associated with a higher prevalence of depression levels (P =< 0.001) and people who were widowed (22.38%), divorced (26%), and separated (37.82%) had significant depression levels (P = 0.017). In terms of anxiety, 54.58% of females had anxiety (P = 0.005), more older people showed anxiety (43.17%) (P = 0.026), and people with a bad general health state (26.38%) had anxiety (P = <0.001). Conclusion Among different types of MS patients, anxiety is more prevalent in the elder group (76%) of people and depression is more prevalent in young patients (62%).
Copyright © 2020, Bahathig et al.

Entities:  

Keywords:  anxiety; depression; multiple sclerosis; neuropsychiatry; prevalence; quality of life; saudi arabia

Year:  2020        PMID: 33532152      PMCID: PMC7845751          DOI: 10.7759/cureus.12389

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  3 in total

1.  Prevalence of Anxiety and Depression in Patients With Multiple Sclerosis in Saudi Arabia: A Cross-Sectional Study.

Authors:  Rahaif H Aljishi; Rahaf J Almatrafi; Zainab A Alzayer; Bayan A Alkhamis; Esraa E Yaseen; Amal M Alkhotani
Journal:  Cureus       Date:  2021-12-29

2.  Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Authors:  Matthew Craner; Yaser Al Malik; Fawzi A Babtain; Foziah Alshamrani; Mona M Alkhawajah; Nora Alfugham; Rumaiza H Al-Yafeai; Salman Aljarallah; Seraj Makkawi; Shireen Qureshi; Marina Ziehn; Hazem Wahba
Journal:  Neurol Ther       Date:  2022-09-01

3.  Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia.

Authors:  Norah A Alharbi; Sadaga H Alawi; Yousef M Alharbi; Muath Y Alharbi; Tareq N Alsamarh; Adi A Aldubaiyan; Saleh A Alwasil; Abdulrahman A Alomairi
Journal:  Neurosciences (Riyadh)       Date:  2022-04       Impact factor: 0.735

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.